Lifestyle travel company Embark Beyond has partnered with health tech firm eMed to provide FDA-approved self-administered rapid Antigen test kits specially designed for re-entry back into the United States.
Embark clients traveling internationally can receive a small COVID test kit to pack in their luggage. Two days prior to returning to the U.S. they can launch a Zoom session with eMed from their room and conduct a self-administered COVID test. The process, which takes about 10 minutes and can be administered anywhere in the world with an Internet connection. Once the results are determined eMed will email “an official negative COVID lab report to the client.”
The partnership, according to Embark, will allow clients to take a test at any time of day, on demand, with no prior appointment necessary and costs about $35 per person. In addition to re-entering the U.S., the tests can also be used to travel to most countries requiring a rapid Antigen to enter.
Every guest can receive test kits in their room upon welcome with a note to test every evening before bedtime. Results can then be uploaded onto Embark’s portal enabling daily testing that doesn’t inconvenience a guest with appointment commitments or queues.
The test kits can also come in handy for Americans who are not vaccinated and traveling in Europe. Since Americans cannot join the E.U. Health Pass program, if they are not vaccinated, they need to re-test for COVID every 48 hours for entry into bars, restaurants, museums or any other venue requiring the EU Health Pass. The eMed kits will help such travelers in re-testing.
Related Articles
Embark Beyond Partners With Teresa Perez Tours in Brazil
WhirlAway Travel's Jamie Jones Revamps for Future Success
Former Norwegian CEO: Rebirth of the Travel Industry Is Coming